type here...

Latest news

Commercial

Kyorin Secures Japanese Rights to Hinge Bio’s Preclinical Lupus Therapy HB2198 in $10M Deal

Kyorin Expands Autoimmune Portfolio with Hinge Bio Deal Kyorin Pharmaceutical has expanded its autoimmune portfolio by entering into a collaboration...
Commercial

Akero’s MASH Success Helps Roche Acquire 89bio For $3.5B

Akero Therapeutics’ progress in liver disease treatment helped draw Roche to 89bio and ultimately drove the companies toward a...
Clinical

Amgen reports Vesalius-CV topline showing Repatha reduces MACE in primary-prevention patients

On the heels of an FDA label expansion in August, Amgen reported that its late-stage Vesalius-CV study showed Repatha...
Clinical

Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

Pfizer’s High-Stakes Bet on Metsera Shows Early Promise Pfizer’s $4.9 billion bet on obesity drugmaker Metsera is beginning to show...
Clinical

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

Hansa Biopharma has reported positive top-line results from its...
Regulatory

Crinetics Gets FDA Green Light For Oral Acromegaly Medicine Palsonify

A New Era for Acromegaly Treatment After almost 20 years...
Clinical

Eli Lilly Ends One Bimagrumab Trial in Obesity Patients with Diabetes

Lilly Halts Key Obesity Drug Trial Eli Lilly has halted one of its two Phase 2 clinical trials of the...
Manufacturing

Moderna Opens U.K. Vaccine Plant as Big Pharma Retreats

Moderna opens its Innovation and Technology Centre in the U.K., boosting mRNA vaccine production, cancer research, and pandemic preparedness...
Regulatory

FDA Brings Dormant Drug to Life as Possible Autism Treatment

Wellcovorin's Second Chance for Autism Symptoms The FDA took the rare step of reopening the approval process for GSK’s Wellcovorin,...
Commercial

Bristol Myers Squibb to Launch Schizophrenia Drug Cobenfy in UK at US Price

Bristol Myers Squibb (BMS) announced plans to launch its...
Clinical

Moderna Reports Strong Immunological Response From Next-Generation COVID-19 Vaccine mNEXSPIKE Against Emerging Strain

Promising Results for Next-Generation Vaccine Moderna has announced promising results...
Clinical

Roche Reports Positive Phase 3 Results for Breast Cancer Drug Giredestrant

A Turning Point for Giredestrant Roche has announced a phase 3 success for its investigational oral selective estrogen receptor degrader...
Commercial

Pfizer agrees to a $4.9 billion upfront purchase of Metsera to strengthen obesity portfolio

Pfizer's Strategic Move into Obesity Market Pfizer has invested money in its research and development efforts related to obesity. After...
Regulatory

CHMP Issues Series of Positive Drug Recommendations Across Multiple Indications

Novo Nordisk's Kyinsu for Type 2 Diabetes A year after Novo Nordisk withdrew its U.S. application for IcoSema as a...
Regulatory

Crinetics Gets FDA Green Light For Oral Acromegaly Medicine Palsonify

A New Era for Acromegaly Treatment After almost 20 years...
Editotial Team -
Commercial

Kyorin Secures Japanese Rights to Hinge Bio’s Preclinical Lupus Therapy HB2198 in $10M Deal

Kyorin Expands Autoimmune Portfolio with Hinge Bio Deal Kyorin Pharmaceutical...
Editotial Team -
Commercial

Biolinq Secures $100 Million to Advance Glucose Biosensor and Expand Commercialization Plans

Biolinq has announced the successful closure of a $100...
Commercial

Incyte agrees to pay $12.6M to settle kickback allegations

A Delaware-based pharmaceutical firm was accused of breaching the Federal False Claim Act by paying rebates and has decided

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Crinetics Gets FDA Green Light For Oral Acromegaly Medicine Palsonify

A New Era for Acromegaly Treatment After almost 20 years...
Editotial Team -

Research & Development

Market Access

Manufacturing

Moderna Halts Plans for Japan mRNA Drug Substance Plant Due to Market Conditions

Moderna has decided not to proceed with its previously...
Manufacturing

Amphastar to Quadruple Manufacturing Capacity at Rancho Cucamonga Headquarters

Amphastar Pharmaceuticals, Inc. has unveiled plans to significantly expand...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Commercial

Kyorin Secures Japanese Rights to Hinge Bio’s Preclinical Lupus Therapy HB2198 in $10M Deal

Kyorin Expands Autoimmune Portfolio with Hinge Bio Deal Kyorin Pharmaceutical...
Editotial Team -

Editor Picks

Must Read

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice